| |
Pharmaceutical Technology and BioPharm International
are CPhI North America Media Sponsors! |
|
|
| |
THESE SESSIONS WILL BE HELD AT DESTINATION INNOVATION ON WEDNESDAY, MAY 17
Wednesday, May 17
8:30AM - 10:00AM
The Contract Services Market: Status and Strategies
Speaker: Jim Miller, President, PharmSource Information Services
Location: Destination Innovation
Track: Insight Brief
Pass Type: Connect Delegate, VIP Attendee, Exhibitor, Exhibitor, Connect Delegate, Expo Premium
Overview:
After several years of aggressive consolidation, the contract services market now features bigger players that offer more diverse services. At the same time, smaller contract service manufacturers are filling the need for smaller run and specialty services. As the bio/pharma market diversifies, will it have the capabilities and capacities that drug owners demand? How will shifts in the political environment in the United States trigger changes to the bio/pharma sector and the supporting contract services market? Industry expert Jim Miller, president of PharmSource Information Services, will share his perspective on the contract services landscape and suggest strategies for outsourcing companies looking to grow in this sector. |
 |
|
|
| |
Wednesday, May 17, 2:30pm - 3:15pm
Quality Practices: Meeting and Exceeding Regulatory Expectations
Speakers:
- Rita Peters, Editorial Director, Pharmaceutical Technology and BioPharm International
- Agnes Shanley, Senior Editor, Pharmaceutical Technology and BioPharm International
Location: Destination Innovation
Track: Insight Brief
Overview: Aging equipment, supplier errors, inadequate QA/QC practices, and other factors can contribute to quality problems and regulatory action for drug companies and contract service providers. The editors of Pharmaceutical Technology and BioPharm International, in conjunction with CPhI North America, conducted an industry-wide survey of the state of quality practices at companies manufacturing drugs for the US market.
The survey results, which will be released during this session, reveal current quality-related practices in bio/pharma organizations and contract manufacturers producing drug products for patients in the US. Respondents share insight on interactions with regulatory authorities, quality challenges, and supplier oversight. The responses identify areas of best practices and areas needing improvement for bio/pharma companies, contract service providers, and regulatory authorities. |
 |
|
|
|
|
|
|
 |
|
| |
These sessions are sponsored by Pharmaceutical Technology & BioPharm International. They will be held at the
DESTINATION INNOVATION.
For more information, visit www.PharmTech.com |
| |
Don't forget to mark your calendars for these impactful presentations.
Day of session, arrive early. Seats are limited. |
| |
|
|
|
|
|
|
|
